CTRI/2022/05/042359进行中（未招募）未知
Prospective, randomized, two-arm, interventional pilot study to evaluate accuracy of a digital platform that validates early risk and severity of Non-alcoholic Fatty Liver Disease (NAFLD) and disease management approach in Indian NAFLD patients - NA
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- IIT Bombay
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Healthy individuals confirmed to be free from NAFLD by the doctor for the Control Group.
- •2. Patients with confirmed NAFLD as indicated in the Liver Profile Tests for the NAFLD Group
- •3. Subjects of age 18 to 60 years.
- •4. Gender -All
- •5. Ability to comply with study visits and provide informed consent.
- •6. Diagnostic data are available for algorithm validation.
- •7. Ability to understand and the willingness to sign a written informed consent document.
排除标准
- •1. Evidence of severe or uncontrolled systemic diseases, active bleeding diathesis, or active infection including hepatitis B, hepatitis C, and HIV.
研究者
相似试验
招募中
4 期
Study to evaluate effect of ten-on-ten syrup in children with Attention Deficit Hyperactivity Disorder (ADHD)CTRI/2024/06/068254Herba Neuva Implex Pvt. Ltd
招募中
不适用
To assess the effect of dietary supplement capsules compared to Placebo capsules on joint healthCTRI/2021/10/037187OmniActive Health Technologies
已完成
2 期
A phase II study to evaluate safety and effectiveness of IND02 Capsules in patients who are SARS-CoV2 positive patients with mild to moderate COVID-19 at COVID management centres offering Ayurvedic care.CTRI/2020/11/029328Indus Biotech Limited118
尚未招募
不适用
To assess the effect of dietary supplement capsules compared toPlacebo capsules on joint healthCTRI/2020/07/026603OmniActive Health Technologies
尚未招募
2 期
A clinical study of Probiotic - Bacillus coagulans LBSC in the treatment of drug-induced constipation.CTRI/2021/08/035889Advanced Enzyme Technologies Ltd